Age and Sex trends in long-term opioid use in two large american health systems between 2000 and 2005

Pain Medicine

Volumn 11, Issue 2, 2010, Pages 248-256

  Thielke, Stephen M ^a   Simoni Wastila, Linda ^b   Edlund, Mark J ^c   DeVries, Andrea ^d   Martin, Bradley C ^c   Braden, Jennifer B ^a   Fan, Ming Yu ^a   Sullivan, Mark D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^d HEALTHCORE INC   (United States)

Author keywords

Aged; Anxiety; Chronic pain; Disparities gender; Mood; Opioids; Prescriptions

Indexed keywords

MORPHINE; OPIATE;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MOOD DISORDER; PRESCRIPTION; PREVALENCE; SEX DIFFERENCE; TREATMENT DURATION; UNITED STATES;

EID: 75249105697     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00740.x     Document Type: Article

References (38)

1. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain 2006, 7(4):225-35.
2. Sullivan MD, Edlund MJ, Fan MY. Trends in use of opioids for non-cancer pain conditions 2000-2005 in Commercial and Medicaid insurance plans: The TROUP study. Pain 2008, 138(2):440-9.
3. Zerzan JT, Morden NE, Soumerai S. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care 2006, 44(11):1005-10.
4. Bell JR. Australian trends in opioid prescribing for chronic non-cancer pain, 1986-1996. Med J Aust 1997, 167(1):26-9.
5. Clausen TG. International opioid consumption. Acta Anaesthesiol Scand 1997, 41(1):162-5. Pt 2
6. Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 2009, 13(9):954-62.
7. Freud T, Brill S, Sherf M. Trend in opioids use for chronic pain treatment at Clalit Health Services (2000-2004). Harefuah 2007, 146(12):99-31.
8. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006, 15(9):618-27.
9. Parsells KJ, Cook SF, Kaufman DW. Prevalence and characteristics of opioid use in the U.S. adult population. Pain 2008, 138(3):508-13.
10. Simoni-Wastila L. The use of abusable prescription drugs: The role of gender. J Womens Health Gend Based Med 2000, 9(3):289-97.
11. Simoni-Wastila L. Increases in opioid medication use: Balancing the good with the bad. Pain 2008, 138(2):245-6.
12. Simoni-Wastila L, Zuckerman IH, Singhal PK, Briesacher B, Hsu VD. National estimates of exposure to prescription drugs with addiction potential in community-dwelling elders. Subst Abus 2005, 26(1):33-42.
13. Federman AD, Litke A, Morrison RS. Association of age with analgesic use for back and joint disorders in outpatient settings. Am J Geriatr Pharmacother 2006, 4(4):306-15.
14. Wisniewski AM, Purdy CH, Blondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis 2008, 27(1):1-11.
15. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006, 166(19):2087-93.
16. Luo X, Pietrobon R, Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine 2004, 29(8):91-90. discussion
17. Tolle SW, Hickman SE, Tilden VP, Bubalo JS, Fromme EK. Trends in opioid use over time: 1997 to 1999. J Palliat Med 2004, 7(1):39-45.
18. Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005, 6(10):662-72.
19. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend 2006, 81(2):103-7.
20. Williams RE, Sampson TJ, Kalilani L, Wurzelmann JI, Janning SW. Epidemiology of opioid pharmacy claims in the United States. J Opioid Manag 2008, 4(3):145-52.
21. Arkansas Medicaid Program Overview. 2008, https://www.medicaid.state.ar.us/Download/general/OverviewSFY08.pdf, Available at: (accessed October 9, 2009
22. National Survey on Drug Use and Health, 2004, 2005, and 2006 [database on the Internet. 2008, http://www.drugabusestatistics.samhsa.gov/2k6State/toc.cfm, Available at: (accessed October 9, 2009
23. Fitzmaurice G. A conundrum in the analysis of change. Nutrition 2001, 17(4):360-1.
24. Fan M-Y, Zhou X-H. A simulation study to compare methods for constructing confidence intervals for the incremental cost-effectiveness ratio. Health Serv Outcomes Res Methodol 2007, 7(1-2):57-77.
25. AHRQ-CCS Category List. 2009, http://www.hcup-us.ahrq.gov/toolssoftware/mhsa/CCS-MHSA_General_05.csv, Available at, (accessed October 9, 2009
26. Health, United States, 2006, Figure 34. 2006, CDC. National Center for Health Statistics, Data from the National Health and Nutrition Examination Survey
27. Joel LA. The fifth vital sign: Pain. Am J Nurs 1999, 99(2):9.
28. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA 1995, 274(23):1874-80. American Pain Society Quality of Care Committee
29. Mularski RA, White-Chu F, Overbay D. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med 2006, 21(6):607-12.
30. Simoni-Wastila L, Yang HK. Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother 2006, 4(4):380-94.
31. Solomon DH, Avorn J, Wang PS. Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum 2006, 55(1):35-41.
32. Ives TJ, Chelminski PR, Hammett-Stabler CA. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006, 6:46.
33. Dilcher AJ. Damned if they do, damned if they don't: The need for a comprehensive public policy to address the inadequate management of pain. Ann Health Law 2004, 13(1):81-144. table of contents
34. Haddox JD, Aronoff GM. Commentary: The potential for unintended consequences from public policy shifts in the treatment of pain. J Law Med Ethics 1998, 26(4):263-2.
35. Chinellato A, Terrazzani G, Walley T, Giusti P. Opioids in Italy: Is marketing more powerful than the law? Lancet 2003, 362(9377):78.
36. Gilson AM, Maurer MA, Joranson DE. State medical board members' beliefs about pain, addiction, and diversion and abuse: A changing regulatory environment. J Pain 2007, 8(9):682-91.
37. Aitken M, Berndt ER, Cutler DM. Prescription drug spending trends in the United States: Looking beyond the turning point. Health Aff (Millwood) 2009, 28(1):w151-60.
38. Hamunen K, Laitinen-Parkkonen P, Paakkari P. What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008, 12(6):705-15.